LAVAL, QC, Canada, Jan 26, 2006 /PRNewswire-FirstCall via COMTEX/ -- Neptune Technologies & Bioressources Inc., (TSX Venture Exchange: NTB), "Neptune" today announced its results for the Second quarter ended November 30th, 2005. Neptune has now obtained its sixth consecutive quarter, of positive EBITDA.
- Second Quarter ended November 30th, 2005:
- Operating revenues increased 22% to $1,445,000 compared to
$1,180,000, for the second quarter in 2004.
- EBITDA increased 106% to $245,000 compared to $119,000 for the second
quarter in 2004.
- Net loss from continuing operations decreased 25%, to $380,000, or
0.015$ per share compared to $503,000, or $0.020 per share, for the
second quarter in 2004.
- Six months ended November 30th, 2005:
- Operating revenues increased 41% to $3,267,000 compared to
$2,314,000, for the same period in 2004.
- EBITDA increased 117% to $587,000 compared to $270,000, for the same
period in 2004.
- Net loss from continuing operations decreased by 14%, to $770,000, or
$0.030 per share, compared to $891,000, or $0.035 per share, for the
same period in 2004.
"The strengthening of our financial position has enabled us to maintain a consistent sales growth from last year and recording our sixth consecutive quarter with a positive EBITDA. Solidifying our financial position gives us the leverage needed to pursue our sales growth in Europe and Asia." stated Mr. Andre Godin, Vice President, Administration and Finance for Neptune Technologies & Bioressources Inc. "With our recent capital reorganization we're in a favourable position to ramp up production as demand increases" added Mr. Godin.
Change to the Board of Directors:
Neptune also announces that Mr. Richard Normandeau, a director of Neptune, nominated by Desjardins Capital de Risque pursuant to a shareholders agreement, advised Neptune of his resignation as a director of Neptune, effective as of January 19th, 2006.
Neptune thanks Mr. Richard Normandeau for his contribution to Neptune and wishes him the best of luck with his future projects.
About Neptune Technologies & Bioressources Inc. :
Neptune Technologies & Bioressources Inc. develops high value added nutritional products from underexploited marine biomasses, such as krill, with its patented extraction process (Neptune OceanExtract(TM)). Using an exclusive process, Neptune Technologies & Bioressources Inc. is well positioned in the $182 billion global nutrition market (Nutrition Business Journal, Oct/Nov 2004) of health and wellness concepts.
Natural biomass extraction is now playing an important role in developing nutrigenomics, the next wave in nutritional research. Through strategic alliances and partnerships, as well as through clinical studies, the Company continues to demonstrate the immense beneficial effects of these products. The Company develops and markets new formulas and new products for specific applications in high growth markets such the nutraceutical, cosmeceutical, biopharmaceutical and nutrigenomics markets.